Latest Threads

The text pertains to a review report and interim financial information for the nine-month period ending on September 30, 2024, related to ADNOC.

ADNOC Distribution reported record financial results for the first nine months of 2024, with an EBITDA of $790 million and a net profit of $501 million. The company achieved a 9.2% increase in fuel volumes, delivering over 11 billion liters, largely due to network expansion and increased international operations. Non-fuel retail gross profit rose by 13% year-on-year, supported by a 9.4% increase in non-fuel transactions. The company also reported strong free cash flow of $537 million and a net debt-to-EBITDA ratio of 0.56x. Operational efficiency improvements contributed to $13 million in OPEX savings, with a target of $50 million in savings by 2028. CEO Eng. Bader Saeed Al Lamki highlighted the company's solid fundamentals and strong financial performance.

PureHealth reported a net profit of AED 1.4 billion and an EBITDA of AED 3.1 billion for the first nine months of 2024. The company's consolidated revenue increased by 56% to AED 19.0 billion, primarily driven by the Hospitals segment and supported by organic growth and acquisitions. EBITDA rose by 26% compared to the same period in 2023, with an EBITDA margin of 16.5%, indicating operational efficiencies. Net profit increased by 13% year-on-year, with a net profit margin of 7.6%. Key acquisitions included Circle Health Group and Sheikh Shakhbout Medical City, while divestments included YAS Clinics Group and Abu Dhabi Stem Cells Centre. The Hospital Segment saw revenues rise by 87% and EBITDA growth of 18%, while the Insurance Segment recorded a 17% increase in revenue and a 60% growth in EBITDA. Total assets grew by 72% to AED 48.4 billion, with a cash balance of AED 8.7 billion. The net cash position was 3.0x EBITDA, with a net cash balance of AED 6.7 billion. Overall, PureHealth demonstrated strong performance and strategic growth in the first nine months of 2024.

The text refers to the interim condensed consolidated financial statements of Pure Health Holding PJSC for the period ending on September 30, 2024.

The Islamic Arab Insurance Company – SALAMA held a board meeting on Wednesday, 30 October 2024, starting at 4:00 pm. Six members attended, achieving a quorum of 86%. The meeting involved discussing and approving administrative matters. The authorized signatory for the meeting was Khaled Barakat, who serves as the General Counsel.

The Emirates Telecommunications Group Company (Etisalat Group) held a Board of Directors meeting on October 30, 2024. During this meeting, the Board approved the review reports and interim condensed consolidated financial statements for the nine-month period ending September 30, 2024. These documents were prepared according to International Financial Reporting Standards (IFRS) and reviewed by independent external auditors. Additionally, the Board discussed other routine matters related to the company's operations and made appropriate decisions. The communication was signed by Hasan Mohamed Al Hosani, the Group Corporate Secretary.

Resolution No. 492 of 2024 involves the temporary suspension of trading for BURJEEL HOLDINGS PLC shares on the Abu Dhabi Securities Exchange (ADX). The suspension is due to a Board of Directors meeting scheduled for 14:00 on November 5, 2024, which coincides with the trading session. Trading will be halted from this time until the results of the meeting are received by ADX. The resolution requires all ADX department heads to implement it within their respective areas. Additionally, the resolution will be communicated to the Securities and Commodities Authority (SCA), the concerned company, all ADX departments, and accredited brokers. The resolution was approved by the authorized person and issued on October 30, 2024.